Influenza Type B
Also known as: Influenza B
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00198 | Oseltamivir | A neuraminidase inhibitor used in the prophylaxis and treatment of influenza. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB00198 | Oseltamivir | Neuraminidase | target |
| DB00198 | Oseltamivir | Sialidase-1 | target |
| DB00198 | Oseltamivir | Sialidase-2 | target |
| DB00198 | Oseltamivir | Multidrug resistance-associated protein 4 | transporter |
| DB00198 | Oseltamivir | Solute carrier family 15 member 1 | transporter |
| DB00198 | Oseltamivir | Solute carrier family 22 member 8 | transporter |
| DB00198 | Oseltamivir | Liver carboxylesterase 1 | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16360 | Anti-SARS-CoV-2 immunoglobulin | 3 | Completed | 1 |
| DB10998 | Influenza A virus A/Brisbane/10/2010 (H1N1) antigen (MDCK cell derived, propiolactone inactivated) | Not Available | Completed | 1 |
| DB10999 | Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (MDCK cell derived, propiolactone inactivated) | Not Available | Completed | 1 |
| DB11000 | Influenza B virus B/Massachusetts/2/2012 antigen (MDCK cell derived, propiolactone inactivated) | Not Available | Completed | 1 |